Nicola Brunetti-Pierri MD
Clinical Biochemical Genetics, Clinical Genetics, Pediatric Medical Genetics
Associate Professor
Join to View Full Profile
2 Greenway PlzSte 900Houston, TX 77046
Phone+1 713-798-1750
Fax+1 713-798-1144
Dr. Brunetti-Pierri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineResidency, Medical Genetics and Genomics, 2005 - 2007
University of Naples Faculty of MedicineClass of 1997
Clinical Trials
- Use of Phenylbutyrate Therapy for Patients With Pyruvate Dehydrogenase Complex Deficiency. Start of enrollment: 2018 Oct 01
- Gene Therapy for Severe Crigler Najjar Syndrome Start of enrollment: 2018 Mar 19
Roles: Principal Investigator
Publications & Presentations
PubMed
- Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapy.Alessandro Rossi, Roberta Romano, Simona Fecarotta, Margherita Dell'Anno, Valentina Pecorella
Med. 2025-04-11 - SNRK tames mTOR against metabolic dysfunction-associated steatotic liver disease.Nicola Brunetti-Pierri, Lisa Bewersdorf, Pavel Strnad
Molecular Therapy. 2025-01-08 - 2 citationsBiomarkers for gene therapy clinical trials of lysosomal storage disorders.Alessandro Rossi, Sabrina Malvagia, Giancarlo la Marca, Giancarlo Parenti, Nicola Brunetti-Pierri
Molecular Therapy. 2024-09-04
Press Mentions
Why Listening to Patients Matters in Rare Disease ResearchApril 10th, 2025
Grant Support
- Adeno Associated Virus (AAV) Gene Therapy For Mucopolysaccharidosis Type IINational Center For Research Resources2010–2011
- Hdad-Mediated Gene Therapy For Hemophilia BNational Heart, Lung, And Blood Institute2009
- Adeno Associated Virus (AAV) Gene Therapy For Mucopolysaccharidosis Type IINational Center For Research Resources2008–2009
- Hdad-Mediated Gene Therapy For Hemophilia BNational Heart, Lung, And Blood Institute2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
